BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20374287)

  • 21. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.
    Conti B; Maier R; Barr AM; Morale MC; Lu X; Sanna PP; Bilbe G; Hoyer D; Bartfai T
    Mol Psychiatry; 2007 Feb; 12(2):167-89. PubMed ID: 17033635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.
    Zhou Y; Spangler R; Schlussman SD; Yuferov VP; Sora I; Ho A; Uhl GR; Kreek MJ
    Synapse; 2002 Sep; 45(4):220-9. PubMed ID: 12125043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice selected for high versus low stress reactivity: a new animal model for affective disorders.
    Touma C; Bunck M; Glasl L; Nussbaumer M; Palme R; Stein H; Wolferstätter M; Zeh R; Zimbelmann M; Holsboer F; Landgraf R
    Psychoneuroendocrinology; 2008 Jul; 33(6):839-62. PubMed ID: 18502051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior.
    Boyle MP; Brewer JA; Funatsu M; Wozniak DF; Tsien JZ; Izumi Y; Muglia LJ
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):473-8. PubMed ID: 15623560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat.
    Rotllant D; Armario A
    Neuroscience; 2005; 130(2):427-34. PubMed ID: 15664699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.
    Kier A; Han J; Jacobson L
    Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial glucocorticoid agonist-like effects of imipramine on hypothalamic-pituitary-adrenocortical activity, thymus weight, and hippocampal glucocorticoid receptors in male C57BL/6 mice.
    Mukherjee K; Knisely A; Jacobson L
    Endocrinology; 2004 Sep; 145(9):4185-91. PubMed ID: 15155572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voluntary exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the adrenal level.
    Droste SK; Chandramohan Y; Hill LE; Linthorst AC; Reul JM
    Neuroendocrinology; 2007; 86(1):26-37. PubMed ID: 17595533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor.
    Vinet J; Carra S; Blom JM; Brunello N; Barden N; Tascedda F
    Neuropharmacology; 2004 Dec; 47(7):1062-9. PubMed ID: 15555640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders.
    Mitsukawa K; Mombereau C; Lötscher E; Uzunov DP; van der Putten H; Flor PJ; Cryan JF
    Neuropsychopharmacology; 2006 Jun; 31(6):1112-22. PubMed ID: 16237391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stress system in depression and neurodegeneration: focus on the human hypothalamus.
    Bao AM; Meynen G; Swaab DF
    Brain Res Rev; 2008 Mar; 57(2):531-53. PubMed ID: 17524488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive compounds from Paecilomyces tenuipes regulating the function of the hypothalamo-hypophyseal system axis in chronic unpredictable stress rats.
    Yin YY; Ming L; Zheng LF; Kan HW; Li CR; Li WP
    Chin Med J (Engl); 2007 Jun; 120(12):1088-92. PubMed ID: 17637227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis.
    Bachmann CG; Linthorst AC; Holsboer F; Reul JM
    Neuropsychopharmacology; 2003 Jun; 28(6):1056-67. PubMed ID: 12700716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lipopolysaccharide and antidepressant drugs on glucocorticoid receptor-mediated gene transcription.
    Budziszewska B; Basta-Kaim A; Kubera M; Jaworska L; Leśkiewicz M; Tetich M; Otczyk M; Zajicova A; Holan V; Lasoń W
    Pharmacol Rep; 2005; 57(4):540-4. PubMed ID: 16129923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications.
    Brady LS; Gold PW; Herkenham M; Lynn AB; Whitfield HJ
    Brain Res; 1992 Feb; 572(1-2):117-25. PubMed ID: 1351783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis.
    Kariagina A; Zonis S; Afkhami M; Romanenko D; Chesnokova V
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E857-63. PubMed ID: 15985451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression].
    Juruena MF; Cleare AJ; Pariante CM
    Braz J Psychiatry; 2004 Sep; 26(3):189-201. PubMed ID: 15645065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder.
    Müller MB; Keck ME; Binder EB; Kresse AE; Hagemeyer TP; Landgraf R; Holsboer F; Uhr M
    Neuropsychopharmacology; 2003 Nov; 28(11):1991-9. PubMed ID: 12888779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of fluoxetine and environmental enrichment reduces postpartum stress-related behaviors through the oxytocinergic system and HPA axis in mice.
    Bashiri H; Houwing DJ; Homberg JR; Salari AA
    Sci Rep; 2021 Apr; 11(1):8518. PubMed ID: 33875712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.